Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Digital Realty Trust, Inc. (DLR) vs Davita Inc (DVA) Price & Performance

Digital Realty Trust, Inc.Trade
Davita IncTrade

Price performance (Past 24H)

Key statistics

Digital Realty Trust, Inc. vs Davita Inc — how do they compare? Digital Realty Trust, Inc. trades at $176.26 (market cap $66.95B), while Davita Inc trades at $175.04 (market cap $11.28B). The key difference: Digital Realty Trust, Inc. is far larger — about 5.9× Davita Inc's market cap, and Digital Realty Trust, Inc. pays a 2.7% dividend while Davita Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Digital Realty Trust, Inc. for 94 Days and Davita Inc for 113 Days on average.

DLRDVA
Market Cap
$66.95B$11.28B
Volume
1,766,660650,294
Sector
Real EstateHealth
52-Week High
$203.91$240.96
52-Week Low
$147.93$103.87
Typical Hold Time
94 Days113 Days
Enterprise Value
$85.67B$24.00B
Dividend Yield
2.7%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Digital Realty Trust, Inc.

DLR trades at $176.07, down 4.65% on the day, with a bearish technical signal from moving averages. The stock shows strong fundamental momentum, with Q2 2026 EPS beating expectations at $1.21 versus $0.4829, and revenue growth from $6.11B in 2025 to a projected $6.8B in 2026. Recent news highlights expansion in AI infrastructure, including a collaboration with Blackfuel and a new Los Angeles cable landing station, positioning the company to capitalize on data center demand.

The outlook for DLR is positive, driven by robust AI-driven demand and a record backlog, though high valuation multiples like a P/E of 88.03 pose a risk if growth slows. Analyst consensus is strongly bullish with a $222.35 price target, but investors face risks from significant capital expenditures and debt levels.

Davita Inc

DaVita (DVA) trades at $177.02, down 1.87% on the day, showing mixed technical signals with a bearish moving average trend but neutral oscillators. Fundamentally, the company demonstrates strong earnings beats with Q2 2026 EPS of $4.02 exceeding expectations of $3.88, while revenue growth continues from $13.64B in 2025 to projected $14.0B in 2026. Recent developments include expanding value-based care partnerships with Humana, potentially benefiting over 10,000 Medicare Advantage members.

The outlook remains cautiously optimistic with 43% analyst buy ratings and a $235.67 consensus price target suggesting 33% upside. However, rising debt-to-asset ratios (65.55% in 2025) and margin pressures from Q2 2026 create headwinds. Key risks include regulatory changes in healthcare reimbursement and competitive pressures in dialysis services.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DLR
100% Buy0% Sell
Avg holding period · 94 Days
DVA
91% Buy9% Sell
Avg holding period · 113 Days

Top news

Latest headlines on both assets

About Digital Realty Trust, Inc.

Digital Realty owns and operates nearly 300 data centers worldwide. It has more than 35 million rentable square feet across five continents. Digital's offerings range from retail co-location, where an enterprise may rent a single cabinet and rely on Digital to provide all the accommodations, to cold shells, where hyperscale cloud service providers can simply rent much, or all, of a barren, power-connected building. In recent years, Digital Realty has de-emphasized cold shells and now primarily provides higher-level service to tenants, which outsource their related IT needs to Digital. Digital Realty has also moved more into the co-location business, increasingly serving enterprises and facilitating network connections. Digital Realty operates as a real estate investment trust.

Read more on DLR →

About Davita Inc

DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.

Read more on DVA →